Inhibition of Influenza Virus Replication by Oseltamivir Derivatives

Characterized by the high morbidity and mortality and seasonal surge, the influenza virus (IV) remains a major public health challenge. Oseltamivir is commonly used as a first-line antiviral. As a neuraminidase inhibitor, it attenuates the penetration of viruses through the mucus on the respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Renee W. Y., Tao, Kin P., Ye, Jiqing, Lui, Kevin K. Y., Yang, Xiao, Ma, Cong, Chan, Paul K. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879189/
https://www.ncbi.nlm.nih.gov/pubmed/35215179
http://dx.doi.org/10.3390/pathogens11020237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879189/
https://www.ncbi.nlm.nih.gov/pubmed/35215179
http://dx.doi.org/10.3390/pathogens11020237

Ejemplares similares